In vitro binding and receptor-mediated activity of terlipressin at vasopressin receptors V1 and V2
Khurram Jamil,1 Stephen Chris Pappas,2 Krishna R Devarakonda1 1Clinical Development, Mallinckrodt Pharmaceuticals, Bedminster, 2Orphan Therapeutics, LLC, Lebanon, NJ, USA Abstract: Terlipressin, a synthetic, systemic vasoconstrictor with selective activity at ­vasopressin-1 (V1) receptors, i...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2017-12-01
|
Series: | Journal of Experimental Pharmacology |
Subjects: | |
Online Access: | https://www.dovepress.com/in-vitro-binding-and-receptor-mediated-activity-of-terlipressin-at-vas-peer-reviewed-fulltext-article-JEP |